Requirement of MyD88 and Fas pathways for the efficacy of allergen-free immunotherapy (2015)
Source: Allergy. Unidades: FCFRP, FCF, FMRP, ICB
Subjects: ANTI-HISTAMÍNICOS H1, ALERGIA E IMUNOLOGIA, IMUNOTERAPIA
ABNT
FONSECA, Denise Morais da et al. Requirement of MyD88 and Fas pathways for the efficacy of allergen-free immunotherapy. Allergy, v. 70, n. 3, p. 275-284, 2015Tradução . . Disponível em: https://doi.org/10.1111/all.12555. Acesso em: 31 ago. 2024.APA
Fonseca, D. M. da, Wowk, P. F., Paula, M. O., Gembre, A. F., Baruffi, M. D., Fermino, M. L., et al. (2015). Requirement of MyD88 and Fas pathways for the efficacy of allergen-free immunotherapy. Allergy, 70( 3), 275-284. doi:10.1111/all.12555NLM
Fonseca DM da, Wowk PF, Paula MO, Gembre AF, Baruffi MD, Fermino ML, Turato WM, Campos LW, Silva CL, Ramos SG, Horn C, Marchal G, Arruda LK de P, Russo M, Bonato VLD. Requirement of MyD88 and Fas pathways for the efficacy of allergen-free immunotherapy [Internet]. Allergy. 2015 ; 70( 3): 275-284.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1111/all.12555Vancouver
Fonseca DM da, Wowk PF, Paula MO, Gembre AF, Baruffi MD, Fermino ML, Turato WM, Campos LW, Silva CL, Ramos SG, Horn C, Marchal G, Arruda LK de P, Russo M, Bonato VLD. Requirement of MyD88 and Fas pathways for the efficacy of allergen-free immunotherapy [Internet]. Allergy. 2015 ; 70( 3): 275-284.[citado 2024 ago. 31 ] Available from: https://doi.org/10.1111/all.12555